No evidence of clinical efficacy of famotidine for the treatment of COVID-19: a systematic review and meta-analysis

被引：16
作者：
Cheema, Huzaifa Ahmad [1 ]
Shafiee, Arman [2 ,3 ]
Athar, Mohammad Mobin Teymouri [4 ]
Shahid, Abia [1 ]
Awan, Rehmat Ullah [5 ]
Afifi, Ahmed M. [6 ]
Shah, Jaffer [7 ]
Jalal, Prasun K. [8 ]
机构：
[1] King Edward Med Univ, Div Infect Dis, Dept Med, Lahore 54000, Punjab, Pakistan
[2] Alborz Univ Med Sci, Clin Res Dev Unit, Karaj, Iran
[3] Alborz Univ Med Sci, Sch Med, Student Res Comm, Karaj, Iran
[4] Shahid Beheshti Univ Med Sci, Sch Med, Tehran, Iran
[5] Ochsner Rush Med Ctr, Dept Med, Meridian, MS USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA
[7] New York State Dept Hlth, Albany, NY USA
[8] Baylor Coll Med, Dept Med, Sect Gastroenterol & Hepatol, Houston, TX 77030 USA
来源：
JOURNAL OF INFECTION | 2023年 / 86卷 / 02期
关键词：
D O I：
10.1016/j.jinf.2022.11.022
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：189 / 191
页数：3
相关论文
共 20 条
  • [1] Comparative study of CNR1 and CNR2 cannabinoid receptors expression levels in COVID-19 patients with and without diabetes mellitus: Recommendations for future research targets
    Aghamahdi, Fatemeh
    Sha, Arman
    Rostami, Sayeh
    Mokhames, Zakiye
    Safavi, Mahshid
    Yaslianifard, Somayeh
    Siami, Zeinab
    Kabir, Kourosh
    Azizi, Gholamreza
    Bakhtiyari, Mahmood
    Mozhgani, Sayed-Hamidreza
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2022, 16 (05)
  • [2] Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trial
    Brennan, Christina M.
    Nadella, Sandeep
    Zhao, Xiang
    Dima, Richard J.
    Jordan-Martin, Nicole
    Demestichas, Breanna R.
    Kleeman, Sam O.
    Ferrer, Miriam
    von Gablenz, Eva Carlotta
    Mourikis, Nicholas
    Rubin, Michael E.
    Adnani, Harsha
    Lee, Hassal
    Ha, Taehoon
    Prum, Soma
    Schleicher, Cheryl B.
    Fox, Sharon S.
    Ryan, Michael G.
    Pili, Christina
    Goldberg, Gary
    Crawford, James M.
    Goodwin, Sara
    Zhang, Xiaoyue
    Preall, Jonathan B.
    Costa, Ana S. H.
    Conigliaro, Joseph
    Masci, Joseph R.
    Yang, Jie
    Tuveson, David A.
    Tracey, Kevin J.
    Janowitz, Tobias
    [J]. GUT, 2022, 71 (05) : 879 - +
  • [3] Chenyu S., DIGEST DIS SCI
  • [4] Effect of famotidine on hospitalized patients with COVID-19: A systematic review and meta-analysis
    Chiu, Leonard
    Shen, Max
    Lo, Chun-Han
    Chiu, Nicholas
    Chen, Austin
    Shin, Hyun Joon
    Prsic, Elizabeth Horn
    Hur, Chin
    Chow, Ronald
    Lebwohl, Benjamin
    [J]. PLOS ONE, 2021, 16 (11):
  • [5] Eugene S., 2021, AM J GASTROENTEROL, V116, pS598, DOI [10.14309/01.ajg.0000778736.01714.cd, DOI 10.14309/01.AJG.0000778736.01714.CD]
  • [6] Efficacy and safety of molnupiravir for COVID-19 patients
    Fatima, Maurish
    Azeem, Saleha
    Saeed, Junaid
    Shahid, Abia
    Cheema, Huzaifa Ahmad
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 102 : 118 - 121
  • [7] Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
    Freedberg, Daniel E.
    Conigliaro, Joseph
    Wang, Timothy C.
    Tracey, Kevin J.
    Callahan, Michael V.
    Abrams, Julian A.
    [J]. GASTROENTEROLOGY, 2020, 159 (03) : 1129 - +
  • [8] Justin W., 2021, AM J GASTROENTEROL, V116, pS668, DOI [10.14309/01.ajg.0000779364.64867.ec, DOI 10.14309/01.AJG.0000779364.64867.EC]
  • [9] Kritas S.K., J BIOL REG HOMEOS AG
  • [10] Impact of Famotidine Use on Clinical Outcomes of Hospitalized Patients With COVID-19
    Mather, Jeffrey F.
    Seip, Richard L.
    McKay, Raymond G.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 (10) : 1617 - 1623
12